Elanco Animal Health INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NYSE
Elanco Animal Health reported a net loss of $232 million in 2025, driven by significant restructuring charges and asset impairments, despite revenue growth and new product launches.
NYSE
Elanco Animal Health's 2024 results highlight strategic shifts, including the divestiture of its aqua business and advancements in its product portfolio.
NYSE
10-K: Elanco Animal Health Reports Full-Year 2023 Results Amid Strategic Shifts and Regulatory Challenges
Elanco Animal Health Incorporated released its full-year 2023 financial results, highlighting a year of strategic acquisitions, restructuring efforts, and a significant goodwill impairment charge, while navigating a complex global market and regulatory environment.